eMedicine Specialties > Radiology > Musculoskeletal

Hyperparathyroidism, Secondary: Imaging

Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Coauthor(s): Farrah Jabeen, MB, BCh, MRCS, FRCR, House Officer, Radiology Training Program, North West Deanery, UK; Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Contributor Information and Disclosures

Updated: Nov 5, 2008

Radiography

Findings


Radiograph of the dorsal spine shows the classic ...

Radiograph of the dorsal spine shows the classic rugger-jersey spine. This results from ill-defined bands of increased bone density adjacent to the vertebral endplates.

Radiograph of the dorsal spine shows the classic ...

Radiograph of the dorsal spine shows the classic rugger-jersey spine. This results from ill-defined bands of increased bone density adjacent to the vertebral endplates.


Radiograph of both hands of a 36-year-old woman r...

Radiograph of both hands of a 36-year-old woman receiving long-term hemodialysis shows subperiosteal bone resorption affecting the radial aspect of the middle phalanges of the fingers. Note the extensive digital arterial calcification.

Radiograph of both hands of a 36-year-old woman r...

Radiograph of both hands of a 36-year-old woman receiving long-term hemodialysis shows subperiosteal bone resorption affecting the radial aspect of the middle phalanges of the fingers. Note the extensive digital arterial calcification.


Plain radiograph of the skull of a 39-year-old wo...

Plain radiograph of the skull of a 39-year-old woman demonstrates malabsorption syndrome with the biochemical features of osteomalacia. The image shows a granular pattern of the skull. Note the brown tumor (arrow).

Plain radiograph of the skull of a 39-year-old wo...

Plain radiograph of the skull of a 39-year-old woman demonstrates malabsorption syndrome with the biochemical features of osteomalacia. The image shows a granular pattern of the skull. Note the brown tumor (arrow).


[See also Images 1-12 in the Multimedia Section.]

Radiography is the most important investigational modality in the diagnosis of secondary hyperparathyroidism; radiographs may show several skeletal abnormalities. The radiologic features of secondary hyperparathyroidism are similar to those of the primary form of the disease. The combination of 2 pathologic processes of hyperparathyroidism and osteomalacia and/or rickets is responsible for the osseous abnormalities in renal osteodystrophy.5

In children, widening of the growth plates of the long bones may be present, with irregularity of the metaphyseal margins and disorganization of the growth plate, which is indicative of advanced rickets. These changes of gross disease have been likened to the rotting of a wooden post at its stem.

Severe osteopenia may be complicated by pathologic fractures. Epiphyseal displacement of metaphyseal fractures may be present; the most commonly involved sites include the distal radius, the proximal humerus, the distal femur, and the heads of metacarpal and metatarsal bones.6

Skeletal maturation may be retarded. Lateral Blount disease may occur as a result of lateral angulation of the proximal tibial epiphysis and genu valgum. Jaw enlargement has been described.

In adults, subperiosteal bone resorption characteristically affects the phalangeal tufts, the radial aspect of the proximal and middle phalanges of the fingers, the metatarsals, the rib margins, the lamina dura, and the medial margins of the proximal humerus, femur, and tibia.

Intracortical bone resorption, which results in a lacy appearance, involves the cortex of the metacarpals. Endosteal resorption may involve the phalanges of the digits. Subligamentous bone resorption affects the tuberosities of the humerus, the ischium, and the greater and lesser femoral trochanters, as well as the inferior surface of the lateral end of the clavicle and the inferior surface of the calcaneus. Subchondral resorption occurs at several sites, including the sternoclavicular and acromioclavicular joints, the symphysis pubis, the sacroiliac joints, and the discovertebral joints. An erosive-type arthropathy is reported with secondary hyperparathyroidism.

Brown tumors occur, but these are less common with secondary hyperparathyroidism than they are with primary hyperparathyroidism. However, as the life expectancy of patients with chronic renal disease has increased, brown tumors have increasingly been identified with renal osteodystrophy. Brown tumors may occur in the spine and form expansile masses, which can be complicated by paraplegia. Brown tumors of the sellar and/or parasellar regions and face may appear as destructive lesions.

The skull may show a granular pattern, which may be associated with thickening, particularly in the inner table. Osteomalacia may be predominant in patients with renal osteodystrophy. Associated Looser transformation zones and pathologic fractures, possibly symmetric, can be present. Osteosclerosis may affect the epiphyses, metaphyses, pelvis, and ribs. Frequently, a classic rugger-jersey spine is observed; it is caused by ill-defined bands of increased bone density adjacent to the vertebral endplates.

An organized periosteal reaction (eg, periosteal neostasis) may develop around the metatarsals, femora, and pelvis. This finding, although not typical, is more common in secondary hyperparathyroidism than it is in the primary form of disease. Generalized osteopenia, often severe, may occur. Digital phalangeal brachydactyly secondary to healed renal osteodystrophy may be present. Rarely, kyphoscoliosis may occur.

Extra-osseous calcification is more common in secondary hyperparathyroidism than it is in the primary form of the disease, and it is even more common in long-standing disease. Abnormal calcification and other abnormalities include the following:

  • Tumoral calcification associated with bone erosions
  • Chondrocalcinosis
  • Vascular calcification
  • Calcified pulmonary nodules
  • Cerebral subcortical calcification
  • Calcification within the eyes
  • Layering of soft-tissue calcification
  • Cardiac calcifications
  • Breast calcifications
  • Renal calcification
  • Hepatic calcification

Degree of Confidence

In renal osteodystrophy, bone resorption is invariably present. Correlation of findings with the patient's history and biochemical parameters should lead to the correct diagnosis. However, secondary hyperparathyroidism associated with osteomalacia of dietary origin may cause vague symptoms and, sometimes, nonspecific biochemical findings.

False Positives/Negatives

The radiologic features of secondary hyperparathyroidism are similar to those of the disease's primary form. The radiologic changes can sometimes mimic those observed in Paget disease.

Computed Tomography

Findings

CT scan findings in renal osteodystrophy include abnormal sacroiliac joints, multiple brown tumors, osteitis fibrosa cystica, prominent Schmorl nodes, periarticular tumoral calcifications, and slipped capital femoral epiphyses.7 Layering of soft-tissue calcification is well demonstrated on CT scans. In general, however, and in comparison with other modalities, CT scanning offers no advantage in the diagnosis of secondary hyperparathyroidism.

Degree of Confidence

CT scanning is rarely employed in screening exams for renal osteodystrophy.7 Nonetheless, knowledge of the CT scan appearances of secondary hyperparathyroidism is important; it helps clinicians avoid confusing the changes associated with secondary hyperparathyroidism with those resulting from other pathologic conditions. On the whole, however, CT scanning is not sensitive in the detection of changes related to secondary hyperparathyroidism.

False Positives/Negatives

Soft-tissue calcification is not specific to secondary hyperparathyroidism and has myriad causes. Erosive changes attributable to secondary hyperparathyroidism may easily be confused with changes in rheumatoid arthritis, seronegative spondyloarthropathies, infection, or even malignancy. Brown tumors and amyloid deposition can easily be mistaken for a neoplastic process.

Magnetic Resonance Imaging

Findings

MRI can adequately reveal skeletal deformity, cortical thickening, and irregular trabecular patterns in children with renal osteodystrophy.7,8 In addition, MRI shows osteonecrosis and intraosseous soft-tissue masses more conspicuously than do plain radiographs. This modality also shows diffuse, nonspecific marrow changes.9  One case describes the MRI diagnosis of thoracic myelopathy caused by spinal stenosis secondary to renal osteodystrophy.10 MRI is also useful in the detection of parathyroid hyperplasia.

Degree of Confidence

Based on current experience, MRI findings in secondary hyperparathyroidism are not specific enough for this modality to replace radiography. Also, MRI has low sensitivity and specificity in the detection of parathyroid hyperplasia.

False Positives/Negatives

MRI findings in chronic osteodystrophy can often mimic those of other diseases.

Ultrasonography

Findings

Ultrasonography is useful in the detection of parathyroid enlargement.11,12

Degree of Confidence

The sensitivity of ultrasonography in the detection of parathyroid hyperplasia is low. Imaging modalities in secondary hyperparathyroidism are of a limited value in guiding medical and surgical treatment. However, if percutaneous alcohol ablation is contemplated as an adjunct to medical treatment, ultrasonography may be useful in the initial localization of an abnormal gland.

False Positives/Negatives

Ultrasonography has a high rate of false-negative findings in the diagnosis of parathyroid hyperplasia. A thyroid tumor may mimic a parathyroid adenoma.

Nuclear Imaging

Findings


Superscan shows diffusely increased activity in t...

Superscan shows diffusely increased activity in the axial skeleton and perhaps in the calvaria and mandible. The ratio of bone to soft tissue is increased, and the kidneys and urinary bladder are absent.

Superscan shows diffusely increased activity in t...

Superscan shows diffusely increased activity in the axial skeleton and perhaps in the calvaria and mandible. The ratio of bone to soft tissue is increased, and the kidneys and urinary bladder are absent.


Technetium-99m bone scan in a patient with chroni...

Technetium-99m bone scan in a patient with chronic renal disease shows uptake in the lungs and calvaria. No renal or bladder activity was noted. (The kidneys are not shown.)

Technetium-99m bone scan in a patient with chroni...

Technetium-99m bone scan in a patient with chronic renal disease shows uptake in the lungs and calvaria. No renal or bladder activity was noted. (The kidneys are not shown.)


Several radionuclide features are reported in secondary hyperparathyroidism. A superscan may reveal the following findings:
  • Diffusely increased activity in bones, specifically in the axial skeleton, calvaria, mandible, costochondral junctions, long bones, and sternum
  • An increased bone-to–soft tissue ratio
  • Absent kidney and urinary bladder findings
Diffuse uptake of a radionuclide (eg, technetium-99m [99m Tc] methylene diphosphonate [MDP]) may occur in the lungs. Metaphyseal fractures may be cold on99m Tc MDP scans. Radionuclide uptake may be observed in ectopic calcific deposits.

Technetium-99m sestamibi and subtraction scintigraphy with thallium-201 (201 Tl) and99m Tc have been used to localize parathyroid hyperplasia in secondary hyperparathyroidism, but they are of limited value.12,13,14,15,16

Degree of Confidence

Radionuclide bone scans have low sensitivity and specificity in the detection of secondary hyperparathyroidism. The use of radionuclides in the diagnosis of parathyroid hyperplasia also has a limited role.

False Positives/Negatives

Besides renal osteodystrophy and/or hyperparathyroidism, the following conditions, displaying the same features as hyperparathyroidism, may appear to be present:

  • Hyperthyroidism
  • Extensive skeletal metastases
  • Aplastic anemia
  • Leukemia
  • Widespread Paget disease
  • Myelofibrosis and/or myelosclerosis
  • Waldenström macroglobulinemia
  • Systemic mastocytosis
Findings on a superscan may be interpreted as normal in patients with poor renal function.

More on Hyperparathyroidism, Secondary

Overview: Hyperparathyroidism, Secondary
Imaging: Hyperparathyroidism, Secondary
Multimedia: Hyperparathyroidism, Secondary
References
Further Reading

References

  1. Cozzolino M, Galassi A, Gallieni M, Brancaccio D. Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol. Curr Vasc Pharmacol. Apr 2008;6(2):148-53. [Medline].

  2. Kovesdy CP, Kalantar-Zadeh K. Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. Feb 20 2008;[Medline].

  3. Malik R. Vitamin D and secondary hyperparathyroidism in the institutionalized elderly: a literature review. J Nutr Elder. 2007;26(3-4):119-38. [Medline].

  4. Ambrosoni P, Olaizola I, Heuguerot C, et al. The role of imaging techniques in the study of renal osteodystrophy. Am J Med Sci. Aug 2000;320(2):90-5. [Medline].

  5. Tigges S, Nance EP, Carpenter WA, et al. Renal osteodystrophy: imaging findings that mimic those of other diseases. AJR Am J Roentgenol. Jul 1995;165(1):143-8. [Medline][Full Text].

  6. Yazgan P, Ozturk A, Orhan I, Sirmatel O, Baba F. Third metatarsal brown tumor with secondary hyperparathyroidism: an atypical localization. J Am Podiatr Med Assoc. Jul-Aug 2008;98(4):314-7. [Medline].

  7. Kuhlman JE, Fishman EK, Siegelman SS. Computed tomographic features of renal osteodystrophy. Orthop Rev. Dec 1989;18(12):1290-5. [Medline].

  8. Olmastroni M, Seracini D, Lavoratti G, et al. Magnetic resonance imaging of renal osteodystrophy in children. Pediatr Radiol. Nov 1997;27(11):865-8. [Medline].

  9. States LJ. Imaging of metabolic bone disease and marrow disorders in children. Radiol Clin North Am. Jul 2001;39(4):749-72. [Medline].

  10. Wagle VG, Rossi AJ, Roberts MP, et al. Thoracic spinal stenosis associated with renal osteodystrophy. Diagnosis based on magnetic resonance imaging and computed tomography. Spine. Aug 1993;18(10):1373-5. [Medline].

  11. Vulpio C, Bossola M, De Gaetano A, Maresca G, Di Stasio E, Spada PL. Ultrasound Patterns of Parathyroid Glands in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. Am J Nephrol. Feb 14 2008;28(4):589-597. [Medline].

  12. Kasai ET, da Silva JW, Mandarim de Lacerda CA, Boasquevisque E. Parathyroid glands: combination of sestamibi-99mTc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands. Rev Esp Med Nucl. Jan 2008;27(1):8-12. [Medline].

  13. Chang CW, Tsue TT, Hermreck AS, et al. Efficacy of preoperative dual-phase sestamibi scanning in hyperparathyroidism. Am J Otolaryngol. Nov-Dec 2000;21(6):355-9. [Medline].

  14. Chen CC, Holder LE, Scovill WA, et al. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med. Jun 1997;38(6):834-9. [Medline][Full Text].

  15. Muros MA, Bravo Soto J, López Ruiz JM, et al. Two-phase scintigraphy with technetium 99m-sestamibi in patients with hyperparathyroidism due to chronic renal failure. Am J Surg. Apr 2007;193(4):438-42. [Medline].

  16. Rademaker P, Meijer S, Piers DA. Parathyroid localization by 201Tl-99mTc subtraction scintigraphy: results in secondary hyperparathyroidism. Acta Endocrinol (Copenh). Oct 1990;123(4):402-4. [Medline].

  17. Amin H, Wall BM, Cooke CR. Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. Jan 2007;333(1):58-62. [Medline].

  18. Falbo SE, Sundaram M, Ballal S, et al. Clinical significance of erosive azotemic osteodystrophy: a prospective masked study. Skeletal Radiol. Feb 1999;28(2):86-9. [Medline].

  19. Gerakis A, Hadjidakis D, Kokkinakis E, et al. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol. Nov-Dec 2000;13(6):437-43. [Medline].

  20. Gonzalez T, Cruz A, Balsa A, et al. Erosive azotemic osteoarthropathy of the hands in chronic ambulatory peritoneal dialysis and hemodialysis. Clin Exp Rheumatol. Jul-Aug 1997;15(4):367-71. [Medline].

  21. Ito M, Ito M, Hayashi K, et al. Evaluation of spinal bone changes in patients with chronic renal failure by CT and MR imaging with pathologic correlation. Acta Radiol. May 1994;35(3):291-5. [Medline].

  22. Leone A, Sundaram M, Cerase A, et al. Destructive spondyloarthropathy of the cervical spine in long-term hemodialyzed patients: a five-year clinical radiological prospective study. Skeletal Radiol. Aug 2001;30(8):431-41. [Medline].

  23. Rejnmark L, Vestergaard P, Mosekilde L. Pre-existing diseases and use of loop diuretics may explain increased mortality in secondary hyperparathyroidism. Clin Endocrinol (Oxf). Feb 13 2008;[Medline].

  24. Roe S, Cassidy MJ. Diagnosis and monitoring of renal osteodystrophy. Curr Opin Nephrol Hypertens. Nov 2000;9(6):675-81. [Medline].

  25. Takeyama H, Tabei I, Ogi S, Yokoyama K, Yamamoto H, Okido I, et al. Usefulness of intraoperative 99m Tc-MIBI-guided detection for recurrent sites in secondary hyperparathyroidism: a case-controlled study. Int J Surg. Jun 2008;6(3):184-8. [Medline].

  26. Von Rueden TJ, Knight L, Moller JH, et al. Coarctation of the aorta associated with aortic valvular atresia. Circulation. Nov 1975;52(5):951-4. [Medline].

  27. Wada A, Sugihara M, Sugimura K, et al. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism. Radiat Med. Jul-Aug 1999;17(4):275-82. [Medline][Full Text].

Further Reading

Procedure guideline for parathyroid scintigraphy.
Society of Nuclear Medicine, Inc - Medical Specialty Society.  1999 Feb (revised 2004 Jun).  6 pages.  NGC:004256

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy.

National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].  2007 Jan.  28 pages.  NGC:005508
 
The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. American Association of Clinical Endocrinologists - Medical Specialty Society
American Association of Endocrine Surgeons - Medical Specialty Society.  2005 Jan-Feb.  6 pages.  NGC:004187
 

Keywords

hyperparathyroidism, secondary hyperparathyroidism, osteitis fibrosa cystica, renal osteodystrophy, pronounced parathyroid gland hyperplasia, end-organ resistance to parathyroid hormone, PTH, chronic renal insufficiency, parathyroid glands, parathyroid disease, endocrine system disease, vitamin D supplementation

Contributor Information and Disclosures

Author

Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP is a member of the following medical societies: American Institute of Ultrasound in Medicine, Radiological Society of North America, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Coauthor(s)

Farrah Jabeen, MB, BCh, MRCS, FRCR, House Officer, Radiology Training Program, North West Deanery, UK
Disclosure: Nothing to disclose.

Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Medical Editor

Leon Lenchik, MD, Director, Densitometry Minifellowship, Assistant Professor, Department of Radiology, Wake Forest University Medical Center
Leon Lenchik, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Wilfred CG Peh, MD, MBBS, FRCP(Glasg), FRCP(Edin), FRCR, Clinical Professor, Faculty of Medicine, National University of Singapore; Senior Consultant Radiologist, Alexandra Hospital, Singapore
Wilfred CG Peh, MD, MBBS, FRCP(Glasg), FRCP(Edin), FRCR is a member of the following medical societies: American Roentgen Ray Society, British Institute of Radiology, International Skeletal Society, Radiological Society of North America, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Felix S Chew, MD, MBA, EdM, Professor, Department of Radiology, Vice Chairman for Radiology Informatics, Section Head of Musculoskeletal Radiology, University of Washington
Felix S Chew, MD, MBA, EdM is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.